Xgeva (Denosumab) 120 Mg Injection
HomeXgeva (Denosumab) 120 Mg Injection
Generic nam e: Denosumab.
Trade name : Xgeva.
Manufacturer information :
Xgeva is manufactured by Amgen Inc.
Xgeva FDA Approval :
Xgeva first approved November 18th, 2010.
Xgeva Indication and Dosage form :
|Osteoporosis||Treatment of men and postmenopausal women with osteoporosis who are at high risk for fracture; treatment to Prolia: 60 mg SC every 6 monthsSupplement with calcium 1000 mg/day and vitamin D 400 IU/day.|
|Aromatase Inhibitor Induced Bone Loss||Women with breast cancer: 60 mg (Prolia) SC.|
|Androgen Deprivation Induced Bone Loss||Men with prostate cancer: 60 mg (Prolia) SC.|
|Skeletal-Related Events||120 mg (1.7 mL).|
|Giant Cell Tumor||120 mg SC.|
|Hypercalcemia of Malignancy||120 mg SC.|
Xgeva (Denosumab) availability in India
- You could import this medicine against import permit on Patient Name.
- Please contact ACT Lifesciences Private Limited for further information.